Bioatla Inc's Comment on Sales, Marketing and Customers
The company serves customers who bill federal programs for products, including healthcare benefit programs such as Medicare, Medicaid, and the Children’s Health Insurance Program. Its customers include private third-party payors and healthcare providers such as physicians, dentists, optometrists, podiatrists, chiropractors, physician assistants, certain advance practice nurses, and teaching hospitals. The markets served encompass federal and state healthcare programs and entities involved in healthcare benefits, items, or services.
BioAtla Demonstrates Promising Phase 2 Clinical Trial Results for Ozuriftamab Vedotin in Treating Heavily Pretreated Squamous Cell Carcinoma of the Head and Neck at ESMO 2024BioAtla, a leading innovator in the realm of biopharmaceutical research, has unveiled compelling data from a Phase 2 clinical trial of its pioneering drug, Ozuriftamab Vedotin, at the European Society for Medical Oncology (ESMO) Annual Meeting 2024. The results revealed meaningful antitumor activity and a manageable safety profile in patients suffering from squamous cell carcinoma of the head and neck (SCCHN) who have undergone extensive prior treatment. In the clinical trial, Ozuriftamab Vedotin was tested across two distinct dosing re...
BioAtla, Inc., a prominent global clinical-stage biotechnology company, has recently made an exciting announcement regarding its participation in the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. The company is set to present a highly anticipated poster showcasing its groundbreaking research on Conditionally Active Biologic (CAB) antibody therapeutics. This conference will be held both virtually and at the renowned McCormick Place Convention Center in Chicago, Illinois, from May 31 to June 4, 2024.The significance of this event cannot be understated, as BioAtla is a leading force in the development and advancement of targeted therapies for the treatment of solid tumors. By harnes...
Bioatla Inc’s Comment on Sales, Marketing and Customers
The company serves customers who bill federal programs for products, including healthcare benefit programs such as Medicare, Medicaid, and the Children’s Health Insurance Program. Its customers include private third-party payors and healthcare providers such as physicians, dentists, optometrists, podiatrists, chiropractors, physician assistants, certain advance practice nurses, and teaching hospitals. The markets served encompass federal and state healthcare programs and entities involved in healthcare benefits, items, or services.
Sources:
Bioatla Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Bioatla Inc’s corporate clients.
For your research, we’ve provided 9 tables on Bioatla Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
